ConcertAI Launches Accelerated Clinical Trials
New enterprise platform powered by CARAai targets faster protocol design, smarter site selection, and real-time study monitoring for sponsors and contract research organizations ConcertAI, a leading oncology real-world evidence and AI SaaS technology company, today unveiled Accelerated Clinical Trials (ACT), an enterprise agentic artificial intelligence (AI) platform designed to automate and inject predictive intelligence across…
